SCHEMBL8723458

SCHEMBL8723458

CC1(C)CCc2c(ccc3ccccc23)O1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 6/20 0.49
▸ KDM4E B2RXH2 4/20 0.49
▸ CYP1A2 P05177 2/20 0.49
▸ CYP2C19 P33261 2/20 0.49
▸ GLA P06280 2/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ SIRT1 Q96EB6 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ LMNA P02545 3/20 0.43
▸ MAPT P10636 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ CDK5 Q00535 1/20 0.41
▸ CDK5R1 Q15078 1/20 0.41
▸ NCOA1 Q15788 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ NCOA3 Q9Y6Q9 1/20 0.41
▸ GAA P10253 1/20 0.37
▸ PDE4D Q08499 1/20 0.37
▸ POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25369585 0.84 KDM4E (0.46) HPGDKDM4ECYP1A2CYP2C19GLA
SCHEMBL30588898 0.84 KDM4E (0.46) HPGDKDM4ECYP1A2CYP2C19GLA
SCHEMBL18029940 0.83 KDM4E (0.46) HPGDKDM4ECYP1A2CYP2C19GLA
SCHEMBL6659911 0.78 KDM4E (0.46) HPGDKDM4ECYP1A2CYP2C19GLA
SCHEMBL5996060 0.73 HPGD (0.43) HPGDKDM4ECYP1A2CYP2C19GLA
SCHEMBL29590196 0.70 KDM4E (0.62) HPGDKDM4EGLAHSD17B10LMNA
SCHEMBL7473565 0.69 KDM4E (0.56) HPGDKDM4ECYP1A2CYP2C19GLA
SCHEMBL30830197 0.69 KDM4E (0.56) HPGDKDM4ECYP1A2CYP2C19GLA
SCHEMBL5312088 0.69 AKT1 (0.56) HPGDLMNAPDE4D
SCHEMBL31545199 0.69 AKT1 (0.56) HPGDLMNAPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998034646-A2 TARGETED ANTIOXIDANTS UNIVERSITY OF HERTFORDSHIRE (GB) 1998-08-13 — — WO disclosed
Send feedback